These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

240 related items for PubMed ID: 7838133

  • 1. Evidence for transcriptional control of human mdr1 gene expression by verapamil in multidrug-resistant leukemic cells.
    Muller C, Goubin F, Ferrandis E, Cornil-Scharwtz I, Bailly JD, Bordier C, Bénard J, Sikic BI, Laurent G.
    Mol Pharmacol; 1995 Jan; 47(1):51-6. PubMed ID: 7838133
    [Abstract] [Full Text] [Related]

  • 2. Molecular mechanisms of loss of beta 2-microglobulin expression in drug-resistant breast cancer sublines and its involvement in drug resistance.
    Ogretmen B, McCauley MD, Safa AR.
    Biochemistry; 1998 Aug 18; 37(33):11679-91. PubMed ID: 9709006
    [Abstract] [Full Text] [Related]

  • 3. Induction of MDR1 gene expression by anthracycline analogues in a human drug resistant leukaemia cell line.
    Hu XF, Slater A, Rischin D, Kantharidis P, Parkin JD, Zalcberg J.
    Br J Cancer; 1999 Feb 18; 79(5-6):831-7. PubMed ID: 10070877
    [Abstract] [Full Text] [Related]

  • 4. Cytogenetic and molecular characterization of tumors in nude mice derived from a multidrug-resistant human leukemia cell line.
    Hill AB, Beck WT, Trent JM.
    Cancer Res; 1988 Jan 15; 48(2):393-8. PubMed ID: 2891436
    [Abstract] [Full Text] [Related]

  • 5. Pharmacological, molecular, and cytogenetic analysis of "atypical" multidrug-resistant human leukemic cells.
    Beck WT, Cirtain MC, Danks MK, Felsted RL, Safa AR, Wolverton JS, Suttle DP, Trent JM.
    Cancer Res; 1987 Oct 15; 47(20):5455-60. PubMed ID: 2888532
    [Abstract] [Full Text] [Related]

  • 6. Effect of duration of exposure to verapamil on vincristine activity against multidrug-resistant human leukemic cell lines.
    Cass CE, Janowska-Wieczorek A, Lynch MA, Sheinin H, Hindenburg AA, Beck WT.
    Cancer Res; 1989 Nov 01; 49(21):5798-804. PubMed ID: 2790792
    [Abstract] [Full Text] [Related]

  • 7. Reversal effects of droloxifene on multidrug resistance in adriamycin-resistant K562 cell line.
    Li J, Xu LZ, Yao JJ, Guo WJ, Xia P, Chen Y.
    Acta Pharmacol Sin; 2001 Nov 01; 22(11):1023-7. PubMed ID: 11749795
    [Abstract] [Full Text] [Related]

  • 8. [Expression of the MDR1 gene in five human cell lines of medullary thyroid cancer and reversion of the resistance to doxorubicine by ciclosporin A and verapamil].
    Massart C, Gibassier J, Lucas C, Pourquier P, Robert J.
    Bull Cancer; 1996 Jan 01; 83(1):39-45. PubMed ID: 8672855
    [Abstract] [Full Text] [Related]

  • 9. Negative regulation of MDR1 promoter activity in MCF-7, but not in multidrug resistant MCF-7/Adr, cells by cross-coupled NF-kappa B/p65 and c-Fos transcription factors and their interaction with the CAAT region.
    Ogretmen B, Safa AR.
    Biochemistry; 1999 Feb 16; 38(7):2189-99. PubMed ID: 10026303
    [Abstract] [Full Text] [Related]

  • 10. Significant transcriptional down-regulation of the human MDR1 gene by beta-naphthoflavone: a proposed hypothesis linking potent CYP gene induction to MDR1 inhibition.
    Nwankwo JO.
    Med Hypotheses; 2007 Feb 16; 68(3):661-9. PubMed ID: 17011724
    [Abstract] [Full Text] [Related]

  • 11. Multidrug resistance in leukemic cell line K562/A02 induced by doxorubicin.
    Yang CZ, Luan FJ, Xiong DS, Liu BR, Xu YF, Gu KS.
    Zhongguo Yao Li Xue Bao; 1995 Jul 16; 16(4):333-7. PubMed ID: 7668104
    [Abstract] [Full Text] [Related]

  • 12. Pervilleine A, a novel tropane alkaloid that reverses the multidrug-resistance phenotype.
    Mi Q, Cui B, Silva GL, Lantvit D, Lim E, Chai H, You M, Hollingshead MG, Mayo JG, Kinghorn AD, Pezzuto JM.
    Cancer Res; 2001 May 15; 61(10):4030-7. PubMed ID: 11358822
    [Abstract] [Full Text] [Related]

  • 13. A structure-function relationship among reserpine and yohimbine analogues in their ability to increase expression of mdr1 and P-glycoprotein in a human colon carcinoma cell line.
    Bhat UG, Winter MA, Pearce HL, Beck WT.
    Mol Pharmacol; 1995 Oct 15; 48(4):682-9. PubMed ID: 7476894
    [Abstract] [Full Text] [Related]

  • 14. Lentivirus-mediated RNA interference reversing the drug-resistance in MDR1 single-factor resistant cell line K562/MDR1.
    Ye X, Liu T, Gong Y, Zheng B, Meng W, Leng Y.
    Leuk Res; 2009 Aug 15; 33(8):1114-9. PubMed ID: 19036441
    [Abstract] [Full Text] [Related]

  • 15. Induction of multidrug resistance in MOLT-4 cells by anticancer agents is closely related to increased expression of functional P-glycoprotein and MDR1 mRNA.
    Liu ZL, Onda K, Tanaka S, Toma T, Hirano T, Oka K.
    Cancer Chemother Pharmacol; 2002 May 15; 49(5):391-7. PubMed ID: 11976833
    [Abstract] [Full Text] [Related]

  • 16. Combined treatment of P-gp-positive L1210/VCR cells by verapamil and all-trans retinoic acid induces down-regulation of P-glycoprotein expression and transport activity.
    Sulová Z, Macejová D, Seres M, Sedlák J, Brtko J, Breier A.
    Toxicol In Vitro; 2008 Feb 15; 22(1):96-105. PubMed ID: 17920233
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Suppression of P-glycoprotein expression and multidrug resistance by DNA cross-linking agents.
    Ihnat MA, Lariviere JP, Warren AJ, La Ronde N, Blaxall JR, Pierre KM, Turpie BW, Hamilton JW.
    Clin Cancer Res; 1997 Aug 15; 3(8):1339-46. PubMed ID: 9815817
    [Abstract] [Full Text] [Related]

  • 19. Resistance to TNF-alpha and adriamycin in the human breast cancer MCF-7 cell line: relationship to MDR1, MnSOD, and TNF gene expression.
    Zyad A, Bénard J, Tursz T, Clarke R, Chouaib S.
    Cancer Res; 1994 Feb 01; 54(3):825-31. PubMed ID: 7905787
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.